Aug 11, 2020
Aridis Pharmaceuticals Announces Second Quarter 2020 Results
Jun 18, 2020
Aridis Pharmaceuticals to Discuss APEX(TM) in Virtual Fireside Chat Hosted by Cantor Fitzgerald on June 25th
May 28, 2020
OrPro Therapeutics Advances a New Inhalation Treatment Approach for COVID-19
May 28, 2020
Microbion Awarded up to $17.1 Million from CARB-X and the Cystic Fibrosis Foundation to Develop Inhaled Antimicrobial for Chronic Respiratory Infections in CF
May 27, 2020
Microbion Corporation Announces Orphan Drug Designation Granted for Pravibismane Suspension for Inhalation by US FDA
May 25, 2020
4DMedical's Lung Imaging Technology Receives FDA Clearance as COVID-19 Intensifies Global Focus on Respiratory Health
May 20, 2020
Insmed to Showcase New Brensocatib Data at American Thoracic Society Virtual Clinical Trials Session
May 15, 2020
Proteostasis Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
May 14, 2020
Armata Pharmaceuticals Announces First Quarter 2020 Results and Provides General Corporate Update
May 14, 2020
Growing Prevalence of Chronic Respiratory Diseases to Help Growth of Global Pulmonary Drug Delivery Devices Market to Reach Valuation Worth US$47,452.8 Mn by 2027 End
May 13, 2020
Spirovant Sciences Appoints Roland Kolbeck, PhD, as Chief Scientific Officer
May 12, 2020
Aridis Pharmaceuticals Announces First Quarter 2020 Results
Apr 30, 2020
Insmed Reports First Quarter 2020 Financial Results and Provides Business Update
Apr 29, 2020
Aridis Pharmaceuticals to Participate in Maxim Group's Infectious Disease Virtual Conference
Apr 23, 2020
Brensocatib (Formerly INS1007) to be Studied in Patients with Severe COVID-19 in Investigator-Initiated Trial
Apr 15, 2020
GI Supply Launches New Device to Protect Pulmonologists and Staff Treating COVID-19 Patients
Apr 14, 2020
Healthcare Worker Protection Added Benefit Of Innovative Nebulizer System From Westmed
Apr 08, 2020
AbbVie Invites Students with Cystic Fibrosis to Apply for the AbbVie CF Scholarship for the 2020-2021 Academic School Year
Apr 08, 2020
Lamellar Biomedical Launches Program Designed to Prevent the Severe Respiratory Effects of COVID-19, Using its Unique LAMELLASOME(TM) Technology
Apr 07, 2020
EmphyCorp N115 News: Reducing the Rate and Spread of COVID-19 with Nasal Nitric Oxide